Nurul Amirah Abdul Manab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nurul Amirah Abdul Manab has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hakimah Yusop
Sector of TB and Leprosy, Division of Disease Control, Ministry of Health Malaysia, Putrajaya, MALAYSIA
1 shared publication - Khalid Ibrahim
Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia
1 shared publication - Mohamad Rodi Isa
Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Jalan Hospital, Sungai Buloh, Malaysia
1 shared publication - Nurhuda Ismail
Universiti Teknologi MARA
1 shared publication - Siti Aishah Abas
Division of Medical Development, Ministry of Health Malaysia, Putrajaya, MALAYSIA
1 shared publication - Siti Munira Yasin
Universiti Teknologi MARA
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 23 (6) , em763
Effectiveness of gamified real-time video-observed therapy for adherence in drug-susceptible tuberculosis: Non-inferiority randomized trial protocol
Tuberculosis (TB) treatment adherence remains challenging despite directly observed treatment, short-course (DOTS). This study will evaluate gamified real-time video-observed therapy (GRVOTS), a smartphone-based adherence intervention, against standard DOTS care among adults with newly diagnosed drug-susceptible pulmonary tuberculosis in Malaysia. In this two-arm, parallel-group, open-label, non-inferiority randomized controlled trial, 70 participants will be allocated 1:1 to GRVOTS or standard DOTS care for six months. A non-inferiority design was selected to determine whether GRVOTS can maintain medication adherence while offering a more flexible treatment-support option rather than universally replacing standard DOTS care. The protocol follows the standard protocol items: recommendations for interventional trials 2025 statement. The primary outcome is medication adherence rate (%), with a prespecified non-inferiority margin of -15 percentage points. Secondary outcomes include medication-adherence behavior, sputum acid-fast bacilli conversion, TB treatment outcomes and intrinsic motivation. Trial registration: Thai clinical trials registry (TCTR20260411006).
- 4 November 2026
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 23 (6) , em763
Open AccessEffectiveness of gamified real-time video-observed therapy for adherence in drug-susceptible tuberculosis: Non-inferiority randomized trial protocol
Tuberculosis (TB) treatment adherence remains challenging despite directly observed treatment, short-course (DOTS). This study will evaluate gamified real-time video-observed therapy (GRVOTS), a smartphone-based adherence intervention, against standard DOTS care among adults with newly diagnosed drug-susceptible pulmonary tuberculosis in Malaysia. In this two-arm, parallel-group, open-label, non-inferiority randomized controlled trial, 70 participants will be allocated 1:1 to GRVOTS or standard DOTS care for six months. A non-inferiority design was selected to determine whether GRVOTS can maintain medication adherence while offering a more flexible treatment-support option rather than universally replacing standard DOTS care. The protocol follows the standard protocol items: recommendations for interventional trials 2025 statement. The primary outcome is medication adherence rate (%), with a prespecified non-inferiority margin of -15 percentage points. Secondary outcomes include medication-adherence behavior, sputum acid-fast bacilli conversion, TB treatment outcomes and intrinsic motivation. Trial registration: Thai clinical trials registry (TCTR20260411006).